The Prior Authorization Crisis and 340B Drug Program Explained
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
The Prior Authorization Crisis and 340B Drug Program Explained
-
Letto da:
-
Di:
A proposito di questo titolo
In this episode of Healthcare Americana, host Christopher Habig talks with neurosurgeon and healthcare policy leader Dr. Anthony DiGiorgio about the growing crisis around prior authorizations. They discuss how complicated approval processes delay urgent care, burden physicians, and put patients at risk. Dr. DiGiorgio explains why smarter, low-friction models such as gold-carding and stronger subspecialty board oversight could help rebuild trust between physicians and payers. The conversation also covers the 340B drug discount program, which Dr. DiGiorgio has testified about before Congress. He explains how a program originally designed to help low-income patients has become a major revenue source for large hospital systems and often increases costs for Medicaid, Medicare, and private insurance. Together, they offer a clear and accessible look at what is broken in these systems and what meaningful reform could achieve.
More on Freedom Healthworks & FreedomDoc Health
Subscribe at https://healthcareamericana.com/
More on Dr. Anthony DiGiorgio
Follow Healthcare Americana: Instagram & LinkedIN